A detailed history of Pathstone Holdings, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 23,595 shares of STRO stock, worth $46,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,595
Previous 23,459 0.58%
Holding current value
$46,482
Previous $68,000 19.12%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$2.88 - $5.01 $391 - $681
136 Added 0.58%
23,595 $81,000
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $1,886 - $3,443
646 Added 2.83%
23,459 $68,000
Q1 2024

May 13, 2024

BUY
$3.27 - $5.65 $74,598 - $128,893
22,813 New
22,813 $128,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $103M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.